# Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed

> **NCT04462926** · NA · UNKNOWN · sponsor: **Azienda Ospedaliero-Universitaria di Modena** · enrollment: 100 (estimated)

## Conditions studied

- Prostate Cancer
- Prostatic Neoplasm
- Urogenital Neoplasms
- Prostatic Disease
- Disease Attributes
- Neoplasms

## Interventions

- **DIAGNOSTIC_TEST:** [68Ga]Ga-PSMA-11 PET/CT

## Key facts

- **NCT ID:** NCT04462926
- **Lead sponsor:** Azienda Ospedaliero-Universitaria di Modena
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-20
- **Primary completion:** 2024-09-20
- **Final completion:** 2024-09-20
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04462926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04462926, "Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04462926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*